CCNE1 and cancer: Deregulation of cyclin E is frequently detected in many types of cancers, as cyclin E gene amplification [41], overexpression of cyclin E mRNA or protein levels [42], [43], decrease of cyclin E turnover [44], and the presence of more active forms of cyclin E [45]–[47].